Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | subfamily S9B unassigned peptidase (S09 family) | 0.0574 | 1 | 1 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0311 | 0.3802 | 0.2744 |
Mycobacterium ulcerans | protease II (oligopeptidase B), PtrB | 0.015 | 0 | 0.5 |
Trypanosoma brucei | Dipeptidyl-peptidase 8-like, putative | 0.0211 | 0.1458 | 0.3835 |
Onchocerca volvulus | Dipeptidyl peptidase family member 1 homolog | 0.0574 | 1 | 1 |
Trypanosoma cruzi | prolyl endopeptidase | 0.0311 | 0.3802 | 1 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S9B | 0.0211 | 0.1458 | 0.3835 |
Mycobacterium leprae | PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) | 0.015 | 0 | 0.5 |
Trypanosoma cruzi | dipeptidyl-peptidase 8-like serine peptidase | 0.0211 | 0.1458 | 0.3835 |
Leishmania major | dipeptidyl-peptidase 8-like serine peptidase, putative,serine peptidase, Clan SC, Family S9B | 0.0211 | 0.1458 | 0.3835 |
Mycobacterium tuberculosis | Probable protease II PtrBa [first part] (oligopeptidase B) | 0.024 | 0.212 | 1 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0311 | 0.3802 | 0.2744 |
Trypanosoma cruzi | serine peptidase, Clan SC, Family S9B | 0.0211 | 0.1458 | 0.3835 |
Toxoplasma gondii | prolyl endopeptidase | 0.0311 | 0.3802 | 1 |
Echinococcus granulosus | prolyl endopeptidase | 0.0311 | 0.3802 | 0.2744 |
Trypanosoma brucei | prolyl endopeptidase | 0.0311 | 0.3802 | 1 |
Echinococcus multilocularis | dipeptidyl aminopeptidaseprotein | 0.0574 | 1 | 1 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0311 | 0.3802 | 0.2744 |
Echinococcus granulosus | dipeptidyl aminopeptidaseprotein | 0.0574 | 1 | 1 |
Leishmania major | prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative | 0.0311 | 0.3802 | 1 |
Echinococcus multilocularis | prolyl endopeptidase | 0.0311 | 0.3802 | 0.2744 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.0574 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.